Skip to main content

Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020–2022

Abstract

Purpose

The aim of the study was to identify settings associated with SARS-CoV-2 transmission throughout the COVID-19 pandemic in France.

Methods

Cases with recent SARS-CoV-2 infection were matched with controls (4:1 ratio) on age, sex, region, population size, and calendar week. Odds ratios for SARS-CoV-2 infection were estimated for nine periods in models adjusting for socio-demographic characteristics, health status, COVID-19 vaccine, and past infection.

Results

Between October 27, 2020 and October 2, 2022, 175,688 cases were matched with 43,922 controls. An increased risk of infection was documented throughout the study for open-space offices compared to offices without open space (OR range across the nine periods: 1.12 to 1.57) and long-distance trains (1.25 to 1.88), and during most of the study for convenience stores (OR range in the periods with increased risk: 1.15 to 1.44), take-away delivery (1.07 to 1.28), car-pooling with relatives (1.09 to 1.68), taxis (1.08 to 1.89), airplanes (1.20 to 1.78), concerts (1.31 to 2.09) and night-clubs (1.45 to 2.95). No increase in transmission was associated with short-distance shared transport, car-pooling booked over platforms, markets, supermarkets and malls, hairdressers, museums, movie theatres, outdoor sports, and swimming pools. The increased risk of infection in bars and restaurants was no longer present in restaurants after reopening in June 2021. It persisted in bars only among those aged under 40 years.

Conclusion

Closed settings in which people are less likely to wear masks were most affected by SARS-CoV-2 transmission and should be the focus of air quality improvement.

ClinicalTrials.gov (03/09/2022)

NCT04607941.

Peer Review reports

Introduction

Identifying settings where transmission of SARS-CoV-2 occurs and quantifying their respective contribution has been central to advise evidence-based mitigation strategies such as social distancing policy, testing practices, contact tracing, and information to the public [1]. As the impact of the pandemic recedes in most countries, knowledge on the settings of transmission can help guide improvement in air quality and individual protection approaches, particularly for elderly or immunocompromised people. Furthermore, drawing all available information from the SARS-CoV-2 pandemic is essential to preparedness efforts: in case of emergence of a new respiratory virus, knowledge derived from SARS-CoV-2 will support a timely and evidence-based public health response.

Throughout the pandemic, numerous factors potentially affecting where SARS-CoV-2 transmission may occur have undergone significant changes, including non-pharmaceutical interventions, vaccine coverage, or the circulating strain.

Several study designs have been used to address this question. Outbreak reports have generated crucial early evidence, particularly in settings with low community transmission, allowing accurate contact tracing [2,3,4,5,6]. Other studies have aimed to screen all contacts of a series of cases and identify in which settings contacts were more likely to result in transmission [7, 8]. These designs often require the correct identification of contacts, which can be difficult for SARS-CoV-2 in case of long-distance airborne transmission [9] or superspreading event: a study in Hong Kong reported that approximately 20% of cases were responsible for 80% of secondary cases [10]. It is especially challenging in locations where unrelated people interact closely, for instance in public transport. Other studies have estimated the risk or odds ratios of infection associated with different settings, through cross-sectional seroprevalence estimates [11,12,13] or case-control designs [14,15,16,17].

While many studies have identified the risk associated with venues such as bars, night-clubs, or public transport, none have provided a long-term outlook to assess potential changes through the pandemic. In the present study, which was conducted over a two-year period, we used a case-control design to identify settings associated with the risk of SARS-CoV-2 infection in France and assess how these evolved through the pandemic.

Methods

We conducted an online case-control study in mainland France from October 2020 to October 2022. The methods of the study have been reported before [18,19,20]. We included cases aged 18 and above with recently diagnosed SARS-CoV-2 infection reported in a national information system: all cases diagnosed through RT-PCR or rapid antigen tests were centralized by the national health insurance system (Caisse nationale d’assurance maladie, CNAM). The CNAM sent email invitations to cases identified within the past week who had previously provided their email address (approximately 55% of all people affiliated with the CNAM, who represent about 89% of the population of mainland France). Both RT-PCR and rapid antigen tests were available free of charge without prescription for the whole duration of the study. After providing consent, participants completed an online questionnaire about sociodemographic information, health status, household description, and recent exposures of interest. The questions focused on the 10 days preceding the onset of the symptoms (or testing if asymptomatic). This period was reduced to 7 days after the emergence of the omicron variant given its shorter incubation period [21]. Following the participation of the cases, controls were enrolled by Ipsos, a market and opinion research company, and matched with cases using a frequency-matched procedure. Matching criteria were age (18–29, 30–54, ≥ 55 years old), sex (male or female as self-reported), region (largest administrative subnational division), size of population in the area of residence, and week of exposure to account for local transmission dynamics.

We did not include potential cases and controls who were under a legal status of curatorship or guardianship at the time of participation. Until February 2021, we included only controls without a past episode of SARS-CoV-2 infection. Eligibility for controls was then extended to people without ongoing SARS-CoV-2 infection. We excluded cases and controls reporting an episode of SARS-CoV-2 infection in the past two months (other than the one leading to their participation for cases). To limit recall errors, we excluded cases who filled the questionnaire over 30 days after the onset of symptoms (or testing if asymptomatic). We allowed repeated participation after at least two months since the last participation from January 2022.

To study the evolution of the risk associated with the exposures of interest over the course of the study, we divided the study period into nine shorter periods, based on incidence, important non-pharmaceutical interventions (stay-at-home orders, curfews, sanitary pass, i.e. a proof of COVID-19 vaccination, past infection, or a recent negative test required to visit a series of places), and the circulating strain (see supplementary methods for further description of periods and non-pharmaceutical interventions throughout the study).

Statistical analysis

For a better matching of controls with cases on the timing of exposure, considering that controls were initially included after the screening of cases, we proceeded to an exact matching procedure of four cases for one control on the calendar week of the outcome date (symptom onset or testing if asymptomatic for cases, questionnaire completion for controls). To account for the random selection of cases in the matching procedure, as those outnumbered controls more than four times, we generated 100 databases of series of four cases matched with one control for each period.

We fitted unconditional logistic regression models to estimate the odds ratios of SARS-CoV-2 infection for the exposures of interest in a model including the matching variables, as well as health-related variables, including COVID-19 vaccine status, past SARS-CoV-2 infection, sociodemographic characteristics (level of education, socio-professional category) and household description. The choice of the adjusting variables was guided by subject matter knowledge to include all measured causes of the exposures, the outcome (SARS-CoV-2 infection), or both, relying on the disjunctive cause criterion [22]. The exposures of interest were included as follows: workplace (work in an office, open-space arrangement, complete or partial remote office), gatherings (professional, private, or religious), retail settings (shops, hairdresser, beauty salon), shared transport (short-distance or long-distance transport, car-pooling), and leisure activities (cultural venues, sports facilities, bars, restaurants, parties, divided into night-clubs or private parties from period 5 onward). No estimate was produced for bars, restaurants, indoor sports facilities, and cultural venues for periods 2 and 3 as they were mostly closed then (odds ratios were estimated for the first period thanks to the inclusion of participants before the start of the stay-at-home orders).

These models were fitted for each of the 100 databases per period. We extracted the coefficients, exponentiated them and retained the median for the point estimate and the 2.5th and 97.5th percentiles for the 95% confidence interval. In complementary models, we explored potential interactions of bars, restaurants, and parties with age categorized as < 40 or ≥ 40 years (p-value for interaction estimated with the median of the 100 estimates). To investigate how viral circulation in the country of destination could affect the risk associated with airplane travel, we calculated the mean daily incidence rate obtained from Ourworldindata.org in the country of destination over period 4 (summer of 2021, emergence of the delta variant) [23].

All statistical analyses were performed using Stata 16.0 (StataCorp, College Station, USA). (See supplementary methods for further description of statistical analysis.)

Ethics approval

This study received ethics approval from the ethics committee Comité de Protection des Personnes Sud Ouest et Outre Mer 1 on September 21, 2020 as required by French regulation on clinical research. The data protection authority, the Commission Nationale de l’Informatique et des Libertés (CNIL) authorized the processing of data on October 21, 2020. Informed consent was obtained from all participants.

This report follows the STROBE reporting guidelines for observational studies.

Results

From October 27, 2020 to October 2, 2022, we sent 11,612,450 email invitations to people with recent SARS-CoV-2 infection, and included 691,454 cases (6.0%) and 57,065 controls. After exclusion of participants with a reported episode of infection in the past two months and cases who responded to the questionnaire over 30 days after symptom onset, and matching of four cases for one control, we included 175,688 cases and 43,922 controls (Fig. 1). The main socio-demographic and health status characteristics are summarized in Table 1. The study population was characterized by a lower proportion of men (33.8% vs. 47.6% in the general population aged 20 and over in France), a higher representation of people aged between 40 and 49 years (26.8% vs. 16.7%) and of residents of the Ile-de-France region (where Paris is located) (22.7% vs. 18.3%).

Fig. 1
figure 1

Flow chart of participant enrollment and matching of cases and controls. Legend: Study conducted in mainland France between October 2020 and October 2022

Table 1 Socio-demographic description of the study population (case-control study in mainland France, October 2020 to October 2022)

We identified several settings associated with an increased risk of infection, including professional settings, shops, shared transport, and leisure activities (Fig. 2, Tables S1-S3).

Fig. 2
figure 2figure 2

Adjusted odds ratios of SARS-CoV-2 infection in a case-control study in France. Legend: The study period was divided in nine shorter study periods based on incidence, the circulating strains (two strains are indicated when the period includes the rise of a new strain), and the main non-pharmaceutical interventions. The colors of the cells refer to 95% confidence intervals’ width: in shades of blue if the upper bound of the 95% CI is < 1, in shades of red if the lower bound of the 95% CI is > 1. Cells are uncolored if the 95% confidence interval includes 1. The empty cells reflect the modifications of the questionnaire through the course of the study. Cases and controls were matched with a 4:1 ratio on sex (female or male), age (in 10-year-age categories), region, size of population of the area of residence, and week of exposure. To account for random selection of cases as those outnumbered controls more than four times, we generated 100 databases for each period with matched sets of 4 cases per control. The odds ratios were estimated in multivariable logistic regression models for each of the periods, adjusting for all the variables shown in the figure as well as the matching variables, household characteristics (number of people in the household, presence of children, type of housing), professional category, health status (body-mass index, smoking status, hypertension, diabetes mellitus, chronic respiratory disease, coronary artery disease, immunosuppression), past episode of infection (categorized as 61–180 days prior or > 180 days prior), and COVID-19 vaccine status (number of doses and time since last dose divided in < 90 days, 90–179 days, ≥ 180 days). The odds ratio and the 95% confidence intervals estimates were inferred through the 50th, 2.5th, and 97.5th percentiles of the 100 estimates for each period. All variables shown here are dummy variables except for one combined variable regarding the workplace. (a): The stay-at-home orders started on 10/30/2020; bars, restaurants, night-clubs, non-essential shops, and cultural venues were then closed. (b): The sanitary pass was a proof of vaccine, past infection, or a recent negative test to enter a series of public spaces; the vaccine pass was implemented on 01/24/2022 to include only proofs of vaccine or past infection. (c): Estimated in people exposed before the start of the stay-at-home orders on 10/30/2020

Regarding the workplace, we found a consistently increased risk associated with working in an open-space office compared with a non-open-space office environment (OR range through the nine periods of the study: 1.12 to 1.57). Remote office was associated with a decreased risk of infection when done only partially in the preceding days (0.72 to 0.90), but often not when the few days spent at the workplace were in an open-space environment (0.72 to 1.09). The risk varied through the study for people reporting working fully remotely, with an OR ranging between 0.67 and 1.64 depending on the period.

The visit of shops was overall not associated with any increased risk of infection. The only exceptions are convenience stores and take-away deliveries for which the risk remained increased through most of the study (periods 4 to 9, OR range: 1.15 to 1.44, and 1.07 to 1.28, respectively). Notably, we found no increased risk in retail facilities involving closer and longer contacts such as hairdressers or beauty salons.

Analyses on shared transport show that most short-distance transport such as buses, tramways or short-distance trains did not increase the risk of infection, except for the metro in which the risk was regularly moderately increased (periods 3, and 7 to 9, OR range: 1.07 to 1.19). On the other hand, long-distance trains and airplanes were associated with a notably increased risk, consistently for train (1.25 to 1.88) and for most of the study for airplanes (periods 2 to 6, and 9, OR range: 1.20 to 1.78). The models were adjusted on abroad travel, suggesting that the effect for airplane was not mediated through visit to a high-incidence country. In a sensitivity analysis, the risk for airplane travel remained increased after adjustment on the mean incidence in the country of destination (period 4: OR 1.58, 95%CI 1.41–1.78, compared with OR 1.67, 95%CI 1.52–1.88 without adjustment). Car travels also appeared to favor transmission in certain circumstances, with increased risks for taxi rides throughout the study in the periods when they were investigated (periods 3 to 9, OR range: 1.08 to 1.89), as well as for car-pooling, but only when traveling with relatives (periods 4 to 9, OR range: 1.09 to 1.68), not when the car-pooling was organized with unrelated persons through a dedicated platform (periods 4 to 9, OR range: 0.45 to 0.59).

Of all the cultural and sports facilities we investigated, we found an increased risk mainly for the attendance of concerts (periods 5 to 9, OR range: 1.31 to 2.09), and less consistently for theatres (periods 6, 7, and 9, OR range: 1.20 to 1.45) and the practice of sports indoors (periods 1, 5, and 7, OR range: 1.11 to 1.23). We found no increased risk associated with other settings such as museums, movie theatres, swimming pools, or martial arts facilities.

We initially identified an increased risk associated with bars and restaurants (as the questionnaire did not distinguish them at first): period 1, OR 1.97 (95%CI 1.84–2.07). As bars and restaurants reopened in the spring of 2021, we found an increased risk for bars (OR 1.57, 95%CI 1.50–1.64) but not for restaurants (OR 0.95, 95%CI 0.89–0.99). The risk gradually decreased afterward for bars, and they were no longer at risk from October 2021 (period 6) onward. However, there were significant interactions of bars with age categorized as under 40 years or 40 and above, with a persistently increased risk in those aged under 40 until the first omicron BA.1 wave (periods 4 to 7, OR range: 1.23 to 2.17) (Tables S5, S6). Attending parties was initially consistently associated with an increased risk, particularly in those aged under 40 (periods 1 to 4, OR range: 1.33 to 3.24) (Tables S4, S5). When we could distinguish private parties from parties in night-clubs, as those reopened in the summer of 2021, we found no increased risk for private parties (no interaction with age, Tables S5, S6). In contrast, the risk was high for night-clubs (e.g., in period 6, OR 2.95, 95%CI 2.64–3.28). It decreased gradually through the various omicron waves in 2022 but remained increased in the last period of the study (omicron BA.4/5 wave, OR 1.54, 95%CI 1.41–1.66), regardless of the age category (Tables S5, S6).

Discussion

This case-control study provides a long-term perspective on the settings most associated with the risk of SARS-CoV-2 infection in mainland France between October 2020 and October 2022. We identified increased risks for on-site office work, particularly in open space environments, professional meetings, concerts, theatres, long-distance public transit, as well as bars and night-clubs. On the other hand, we found no increased risk for most sports and cultural activities, religious gatherings, shops, and short-distance public transport.

All settings associated with an increased risk of infection in our study are characterized by varying degrees of common characteristics: mostly indoor settings with little air renewal, where contacts are close, numerous, often maskless, sometimes including singing or shouting, and usually last more than a mere few minutes. These factors are in line with knowledge on the conditions allowing transmission of SARS-CoV-2, through direct contact, large droplets, or fine aerosols [9, 24], often indoors [25].

Apart from bars, restaurants, and night-clubs for which the risk decreased through the course of the study, the associations remained overall relatively stable. Following the implementation of the sanitary pass in most indoor places and long-distance transport in August 2021 (period 5 onwards), we observed a slight decrease in the risk associated with airplane travel, long-distance train, and bars, suggesting the sanitary pass contributed to decrease the risk of transmission in those environments. The odds ratios increased again in period 6 (October 2 to December 19, 2021). While this increase must be interpreted with caution given its limited amplitude, it may also result from a rapidly waning vaccine effectiveness on SARS-CoV-2 transmission [26], as the majority of the adult population was vaccinated between June and August 2021. Other factors could explain the decrease of the risk for bars and restaurants: night-clubs were closed from March 2020 until July 2021, and people may have been more prone to attend parties with closer and longer interactions in bars and restaurants during that time than in the later periods. The interaction of parties and bars with age, with higher odds ratios observed for people aged under 40, suggests the role of behavioral patterns in those environments. The summer of 2021 was also characterized by an important football European competition, during which public viewing in bars was popular and likely contributed to viral circulation. Another hypothesis is that the transmission of the more contagious delta and omicron variants did not require as favorable conditions as the previous strains, leading to a less differentiated risk between people visiting these settings and people who avoided them. Studies on the evolution of settings of transmission through the emergence of the various strains in other countries would help explore this hypothesis.

Findings of other studies on settings of transmission are overall consistent with ours. The decreased risk for people reporting working remotely was also shown in several other studies [16, 27,28,29], whereas the role of open-space offices has been little studied [30]. The fact that people working in open-space offices while also working partially remotely were not at lower risk of infection suggests that the benefit of remote office was offset by the increased risk in open-space offices. The varying results for complete remote office suggest residual confounding in our analysis; these people were possibly exposed to SARS-CoV-2 transmission in other settings that they were more likely to visit, or in the household, in ways that our models could not account for. The absence of increased risk for retail facilities, as well as hairdressers and beauty salons, also reported by others [14,15,16,17, 27, 31,32,33], suggests that these facilities had low enough density and stringent enough measures to effectively limit transmission. Findings on shared transport, often studied altogether without distinction of the duration of the trip, have yielded conflicting evidence [12, 14, 27, 32, 34, 35]. A contact-tracing study on air travel in Ireland has underlined the role of the duration of the flight, with secondary attack rates reaching 14.9% for flights lasting over 5 h vs. 6.3% for shorter ones [36]. The contrast we found between short- and long-distance shared transport supports the importance of the duration spent onboard. Long-distance bus travels were inconsistently at increased risk, which might result from better air renewal during the mandatory driving breaks compared to other shared transport.

Consistent with several other studies, we found no increased risk for cultural venues, sports facilities, and religious gatherings, apart from a slightly increased risk in theaters, concerts, and indoor sports facilities [14, 15, 17, 27, 31, 37]. Findings on dining and partying venues often reported an increased risk for bars [14, 15, 17, 27, 38, 39], night-clubs and parties [17, 27, 39], whereas findings are more conflicted for restaurants [15, 27, 31, 32, 38, 40]. In a case-control study in Denmark conducted in June 2021, Munch and colleagues found an increased risk for the attendance of restaurants or cafés only for people reporting alcohol consumption [31]. This highlights the role of behaviors within those settings on the risk of transmission. Two randomized trials conducted in France found no increased risk of SARS-CoV-2 infection in participants of mass gatherings with strict requirements for attendance, one at a concert [41] and one in a nightclub [42]. These experimentations offer clues for continuation of mass indoor gatherings in case of an emerging respiratory pathogen.

Our findings suggest a graduation in the risk of transmission which combines degree of air renewal and behaviors. We did not observe excess transmission in indoor places where consistent mask-wearing was possible such as museums, movie theatres, shopping malls, or beauty salons. In bars and restaurants, reopening in mid-2021 was associated with recommendations for spacing tables and opening doors and windows. In this context, increased risk of transmission was observed only for those younger than 40 years of age, or during special events like the European soccer championship, suggesting that opening doors and windows might have been protective provided individuals avoided staying too close to one another, and talking loudly or shouting. In closed spaces where opening doors and windows may be absent or limited, and mask wearing not maintained systematically (e.g., during meals in long-distance trains, or drinks in night-clubs), increased risk of transmission was observed. In such places, investment in improving air renewal or filtration would be essential to improve air quality and decrease transmission risk. These investments are costly but have potential long-term benefits on population health [43] and should be properly evaluated for their feasibility and effectiveness.

The main limitation of the present study lies in the low participation rate (6.0%). As in other studies conducted online, we observed notable differences between our study population and the source population: we included a more female population, often in intermediary age groups, and with a higher education level [44, 45]. These demographic factors were included in our matching procedure or in the adjusted models, thus limiting the risk of recruitment bias. This does however decrease the generalizability of our findings. Furthermore, unexpected findings such as the intermittently increased risk associated with complete remote office, with take-away delivery, or the decreased risk for supermarkets illustrate potential recruitment bias, residual confounding, or result from the multiplicity of comparisons. These biases are difficult to avoid entirely in a case-control study. We chose this design nonetheless as it enabled us to modify the questionnaire whenever necessary (introducing questions on the vaccine status, variants, etc.). It provided results soon after the beginning of the study which helped evidence-based decision-making in a time of high burden of SARS-CoV-2 in France [18, 20]. Since the incubation period of COVID-19 only lasts a few days, we considered the risk of recall bias, a frequent limitation of case-control studies, would be low, although we cannot rule out that cases recalled exposures more precisely than controls as they retrospectively tried to identify the circumstances of infection. Cases and controls differed significantly regarding past infection status, an inclusion bias whose impact was likely mitigated by the adjustment on past infection status in the multivariable models. The consistency of the present findings with those of other studies using different designs, such as cross-sectional seroprevalence estimates or prospective cohorts, also supports the validity of our approach. Despite significant power, our study could not assess finer exposures or behaviors associated with certain settings. We cannot exclude for instance that the increased risk associated with train or air travel was caused by exposures at the train station or the airport, or that specific partying venues might have been safe provided they implemented distancing or testing practices.

Overall, this case-control study shows that the workplace, long-distance shared transport, and several leisure activities were likely settings of effective SARS-CoV-2 transmission during the pandemic in mainland France. These findings will help focusing efforts on improvement in air quality and inform pandemic preparedness strategies.

Data availability

The data that support the findings of this study are available from Institut Pasteur. Restrictions apply to the availability of these data, which were used under authorized agreement for this study from the data protection authority, the Commission Nationale de l’Informatique et des Libertés (CNIL). Access to these pseudonymized data would therefore require prior authorization by the CNIL.

References

  1. Cevik M, Marcus JL, Buckee C, Smith TC. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics should inform policy. Clin Infect Dis. 2020;73(Suppl 2):S170–6.

    PubMed Central  Google Scholar 

  2. Capon A, Houston J, Rockett R, Sheppeard V, Chaverot S, Arnott A, et al. Risk factors leading to COVID-19 cases in a Sydney restaurant. Aust N Z J Public Health. 2021;45:512–6.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Finci I, Siebenbaum R, Richtzenhain J, Edwards A, Rau C, Ehrhardt J, et al. Risk factors associated with an outbreak of COVID-19 in a meat processing plant in southern Germany, April to June 2020. Euro Surveill. 2022;27:2100354.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Shen Y, Li C, Dong H, Wang Z, Martinez L, Sun Z, et al. Community Outbreak Investigation of SARS-CoV-2 transmission among Bus riders in Eastern China. JAMA Intern Med. 2020. https://doi.org/10.1001/jamainternmed.2020.5225.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Speake H, Phillips A, Chong T, Sikazwe C, Levy A, Lang J, et al. Flight-Associated transmission of severe Acute Respiratory Syndrome Coronavirus 2 corroborated by whole-genome sequencing. Emerg Infect Dis. 2020;26:2872–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Deslandes A, Calba C, Mahdjoub S, Zhu-Soubise A, Mathey D, Ardoin A. Superspreading events of SARS-CoV-2 in Paris: a retrospective analysis of data from the first wave of COVID-19 in 2020. J Infect Public Health. 2021;14:1733–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Luo L, Liu D, Liao X, Wu X, Jing Q, Zheng J, et al. Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study. Ann Intern Med. 2020;173:879–87.

    Article  PubMed  Google Scholar 

  8. Wu Y, Song S, Kao Q, Kong Q, Sun Z, Wang B. Risk of SARS-CoV-2 infection among contacts of individuals with COVID-19 in Hangzhou, China. Public Health. 2020;185:57–9.

    Article  CAS  PubMed  Google Scholar 

  9. Leung NHL. Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol. 2021;19:528–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Adam DC, Wu P, Wong JY, Lau EHY, Tsang TK, Cauchemez S, et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med. 2020;26:1714–9.

    Article  CAS  PubMed  Google Scholar 

  11. Meylan S, Dafni U, Lamoth F, Tsourti Z, Lobritz MA, Regina J, et al. SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study. BMJ Open. 2021;11:e049232.

    Article  PubMed  Google Scholar 

  12. Talaei M, Faustini S, Holt H, Jolliffe DA, Vivaldi G, Greenig M, et al. Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK). BMC Med. 2022;20:87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Costa SF, Giavina-Bianchi P, Buss L, Mesquita Peres CH, Rafael MM, Dos Santos LGN, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence and risk factors among Oligo/Asymptomatic Healthcare Workers: estimating the impact of Community Transmission. Clin Infect Dis. 2021;73:e1214–8.

    Article  CAS  PubMed  Google Scholar 

  14. Cajar MD, Tan FCC, Boisen MK, Krog SM, Nolsoee R, Collatz Christensen H, et al. Behavioral factors associated with SARS-CoV-2 infection. BMJ Open. 2022;12:e056393.

    Article  PubMed  Google Scholar 

  15. Munch PK, Espenhain L, Hansen CH, Müller L, Krause TG, Ethelberg S. Societal activities associated with SARS-CoV-2 infection: a case-control study in Denmark, November 2020. Epidemiol Infect. 2021;150:e9.

    Article  PubMed  Google Scholar 

  16. Leite A, Leão T, Soares P, Severo M, Moniz M, Lucas R, et al. A case-control study of contextual factors for SARS-CoV-2 transmission. Front Public Health. 2021;9:772782.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Levi M, Cereda G, Cipriani F, Voller F, Baccini M. Case-control study on the routes of transmission of SARS-CoV-2 after the Third Pandemic Wave in Tuscany, Central Italy. Int J Environ Res Public Health. 2023;20:1912.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Galmiche S, Charmet T, Schaeffer L, Paireau J, Grant R, Chény O, et al. Exposures associated with SARS-CoV-2 infection in France: a nationwide online case-control study. Lancet Reg Health Eur. 2021;7:100148.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, et al. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: results from a nationwide case-control study in France. Lancet Reg Health Eur. 2021;8:100171.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Grant R, Charmet T, Schaeffer L, Galmiche S, Madec Y, Von Platen C et al. Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: results from a nationwide case-control study in France. Lancet Reg Health Eur. 2021;:100278.

  21. Galmiche S, Cortier T, Charmet T, Schaeffer L, Chény O, von Platen C, et al. SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study. Lancet Microbe. 2023;4:e409–17.

    Article  PubMed  PubMed Central  Google Scholar 

  22. VanderWeele TJ. Principles of confounder selection. Eur J Epidemiol. 2019;34:211–9.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ourworldindata. COVID-19 Data Explorer. Our World in Data. https://ourworldindata.org/explorers/coronavirus-data-explorer. Accessed 20 Jun 2023.

  24. Greenhalgh T, Jimenez JL, Prather KA, Tufekci Z, Fisman D, Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397:1603–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bulfone TC, Malekinejad M, Rutherford GW, Razani N. Outdoor Transmission of SARS-CoV-2 and other respiratory viruses: a systematic review. J Infect Dis. 2021;223:550–61.

    Article  CAS  PubMed  Google Scholar 

  26. Eyre DW, Taylor D, Purver M, Chapman D, Fowler T, Pouwels KB, et al. Effect of Covid-19 vaccination on transmission of alpha and Delta variants. N Engl J Med. 2022;386:744–56.

    Article  CAS  PubMed  Google Scholar 

  27. Hoskins S, Beale S, Nguyen V, Boukari Y, Yavlinsky A, Kovar J, et al. Relative contribution of essential and non-essential activities to SARS-CoV-2 transmission following the lifting of public health restrictions in England and Wales. Epidemiol Infect. 2022;151:e3.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Meza E, Cummings KJ, Vergara XP, Lai KW, Lim E, Lamba K, et al. Evaluating the association between in-person work and the risk of SARS-CoV-2 infection through June 2021. Am J Ind Med. 2023;66:222–32.

    Article  CAS  PubMed  Google Scholar 

  29. Shah MM, Spencer BR, Feldstein LR, Haynes JM, Benoit TJ, Saydah SH et al. Occupations Associated with SARS-CoV-2 infection and vaccination, U.S. blood donors, July 2021-December 2021. Clin Infect Dis. 2022;:ciac883.

  30. Weissberg D, Böni J, Rampini SK, Kufner V, Zaheri M, Schreiber PW, et al. Does respiratory co-infection facilitate dispersal of SARS-CoV-2? Investigation of a super-spreading event in an open-space office. Antimicrob Resist Infect Control. 2020;9:191.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Munch PK, Espenhain L, Hansen CH, Krause TG, Ethelberg S. Case-control study of activities associated with SARS-CoV-2 infection in an adult unvaccinated population and overview of societal COVID-19 epidemic counter measures in Denmark. PLoS ONE. 2022;17:e0268849.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Smith-Jeffcoat SE, Sleweon S, Koh M, Khalil GM, Schechter MC, Rebolledo PA, et al. Risk-factors for exposure Associated with SARS-CoV-2 detection after recent known or potential COVID-19 exposures among patients seeking Medical Care at a large Urban, Public Hospital in Fulton County, Georgia - A Cross-sectional Investigation. Front Public Health. 2022;10:809356.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Klein C, Borsche M, Balck A, Föh B, Rahmöller J, Peters E, et al. One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: a model for population-based monitoring of infection risk. Sci Adv. 2022;8:eabm5016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Ellingjord-Dale M, Kalleberg KT, Istre MS, Nygaard AB, Brunvoll SH, Eggesbø LM, et al. The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway. BMC Infect Dis. 2022;22:252.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Amer F, Gil-Conesa M, Carlos S, Ariño AH, Carmona-Torre F, Martínez-González MA, et al. Behavioral and personal characteristics Associated with risk of SARS-CoV-2 infection in a Spanish University Cohort. Am J Epidemiol. 2023;192:1463–74.

    Article  PubMed  PubMed Central  Google Scholar 

  36. White PF, Boland M, O’Sullivan MB, Bambury N, Deignan P, Dean J, et al. Transmission of SARS-CoV-2 arising from international flights arriving in Ireland in December 2020: a descriptive analysis using national surveillance data. Public Health. 2022;204:49–53.

    Article  PubMed  Google Scholar 

  37. Kahlert C, Persi R, Güsewell S, Egger T, Leal-Neto O, Sumer J et al. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - a multicentre cross-sectional study. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2021;27.

  38. Arashiro T, Arima Y, Muraoka H, Sato A, Oba K, Uehara Y, et al. Behavioral factors associated with SARS-CoV-2 infection in Japan. Influenza Other Respir Viruses. 2022;16:952–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Cummings KJ, Clarkberg M, Busche J, Travis AJ, Meredith GR, Weisfuse I, et al. Case-control study to identify risk factors for SARS-CoV-2 infection among university students in the northeastern USA. Transbound Emerg Dis. 2022;69:e2688–93.

    Article  CAS  PubMed  Google Scholar 

  40. Lin A, Vittinghoff E, Olgin J, Peyser N, Aung S, Joyce S, et al. Predictors of incident SARS-CoV-2 infections in an international prospective cohort study. BMJ Open. 2021;11:e052025.

    Article  PubMed  Google Scholar 

  41. Delaugerre C, Foissac F, Abdoul H, Masson G, Choupeaux L, Dufour E, et al. Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial. Lancet Infect Dis. 2022;22:341–8.

    Article  CAS  PubMed  Google Scholar 

  42. Luong Nguyen LB, Goupil de Bouillé J, Menant L, Noret M, Dumas A, Salmona M et al. A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study). Clin Infect Dis. 2023;:ciad603.

  43. Cheek E, Guercio V, Shrubsole C, Dimitroulopoulou S. Portable air purification: review of impacts on indoor air quality and health. Sci Total Environ. 2021;766:142585.

    Article  CAS  PubMed  Google Scholar 

  44. Smith W. Does Gender Influence Online Survey Participation? A Record-Linkage Analysis of University Faculty Online Survey Response Behavior. Online Submission. 2008.

  45. Jang M, Vorderstrasse A. Socioeconomic status and racial or ethnic differences in participation: web-based survey. JMIR Res Protoc. 2019;8:e11865.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all those who participated in the study. We thank the Caisse nationale d’assurance maladie, in particular Sophie Martin, Anne Lévy, and Carole Blanc for their collaboration. We thank the Ipsos public affairs department, particularly Nathan Jeandet. We also thank Cassandre von Platen at the Clinical research coordination office at the Institut Pasteur.

Funding

The study was funded by Institut Pasteur, Research, Action Emerging Infectious Diseases (REACTing), and the French Agency Agence nationale de recherches sur le sida et les hépatites virales - Maladies Infectieuses Emergentes (ComCor project). AF’s laboratory receives support from the LabEx Integrative Biology of Emerging Infectious Diseases (IBEID) (ANR-10-LABX-62-IBEID) and the INCEPTION project (PIA/ANR-16-CONV-0005) for studies on emerging viruses. SG is funded by the INCEPTION program “Investissement d’Avenir grant ANR-16-CONV-0005”.

Author information

Authors and Affiliations

Authors

Contributions

AF, SG, TC, FO, CD, FC, and AM designed the investigation.SG, TC, AF, and AM developed the study questionnaire.TC, FO, and CD managed the online data collection.OC, SG, and TC oversaw the adherence of the study to regulatory requirements.TC oversaw the collection of the data and maintained the database.SG, TC, AR and AF performed the statistical analyses.SG and AF drafted the first versions of the manuscript.SG, TC, AR, and AF had full access to the data reported in this study.SG and AF take responsibility for the integrity of the data and the accuracy of the data analysis.All authors critically reviewed and approved the final version of the manuscript.

Corresponding author

Correspondence to Simon Galmiche.

Ethics declarations

Ethics approval and consent to participate

This study was performed in line with the principles of the Declaration of Helsinki. This study received ethics approval from the ethics committee Comité de Protection des Personnes Sud Ouest et Outre Mer 1 on September 21, 2020, as required by French regulation on clinical research. Informed consent was obtained from all participants included in the study.

Consent for publication

Not applicable.

Competing interests

Fabrice Carrat declares consulting fee from Sanofi on influenza epidemiology. Authors declare no further interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galmiche, S., Charmet, T., Rakover, A. et al. Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020–2022. BMC Public Health 24, 2411 (2024). https://doi.org/10.1186/s12889-024-19651-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-024-19651-y

Keywords